Mexico Clinical Nutrition Market Analysis

Mexico Clinical Nutrition Market Executive Summary

The Mexico Clinical Nutrition Market is at around $460.1 Mn in 2023 and is projected to reach $673.2 Mn in 2030, exhibiting a CAGR of 5.59% during the forecast period 2023-2030.

The use of dietary concepts to promote health and prevent disease in individuals, especially in a healthcare context, is known as clinical nutrition. In order to enhance health outcomes, it entails determining the dietary needs of each patient, developing individualized nutrition programs, and putting evidence-based therapies into practice. Clinical nutrition is largely concerned with the diagnosis, treatment, and prevention of dietary modifications in patients with long-term illnesses and ailments in the medical field. In this context, "clinical" refers to the treatment of patients, encompassing both inpatients at hospitals and outpatients at clinics and private practices.

It mainly encompasses the scientific domains of dietetics and nutrition. In addition, clinical nutrition tries to give patients enough protein, vitamin, and mineral intake in addition to preserving a balanced energy system. When a problem is referred to as clinical malnutrition, it means that it can be treated with clinical intervention utilizing specific nutrients that are regarded as legitimate pharmaceuticals as opposed to supplements. By giving the body enough supplements, such as vitamins, minerals, and other nutrients, clinical nutrition solutions help patients stay healthy and strengthen their metabolic system. Advances in medical research and technology are driving a shift in the clinical nutrition industry. Emerging key themes include the use of bioactive substances, customized nutrition solutions, and inventive formulations. Producers are investing in research and development in order to create goods that meet basic nutritional needs while also offering additional health benefits.

Clinical nutritionists or registered dietitians work in hospitals, clinics, and other healthcare facilities to, assess patients' nutritional status, develop personalized nutrition plans, provide nutrition education, manage nutrition-related diseases like diabetes, malnutrition etc, support optimal health and well-being. Some areas of focus in clinical nutrition include, critical care nutrition, paediatric nutrition, oncology nutrition, gastrointestinal nutrition, sports nutrition etc.

Mexico has seen a significant rise in the prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases. According to the International Diabetes Federation, the prevalence of diabetes in Mexico was 12.8% in 2021, affecting approximately 13.5 Mn adults. The major drivers of Clinical Nutrition industry in Mexico are, increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients.

Some of the major players operating in the Mexico Clinical Nutrition market are Amway, Herbalife, Nestle, Abbott Nutrition, Pfizer Inc, Nestle among others.

Market Dynamics

Market Drivers

Increasing Prevalence of Chronic Diseases: Mexico has seen a significant rise in the prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases. According to the International Diabetes Federation, the prevalence of diabetes in Mexico was 12.8% in 2021, affecting approximately 13.5 Mn adults. This growing burden of chronic conditions has led to greater demand for specialized clinical nutrition products to help manage these diseases.

Aging Population: Mexico's population is aging, with the number of people aged 65 and above expected to increase from 7.2% in 2020 to 11.9% by 2030. As people age, their nutritional needs change, and clinical nutrition plays a crucial role in addressing the specific dietary requirements of older adults. The growing geriatric population is a key driver of the clinical nutrition market in Mexico.

Rising Healthcare Expenditure: Mexico has been increasing its healthcare expenditure in recent years, with total health expenditure as a percentage of GDP reaching 5.5% in 2019. This increased investment in the healthcare system has led to improved access to specialized medical services, including clinical nutrition interventions.

Market Restraints

Affordability and Access Barriers: Clinical nutrition products, particularly specialized formulas and supplements, can be relatively expensive in Mexico. This poses affordability challenges, especially for lower-income consumers who could potentially benefit the most from these products. Additionally, the availability and accessibility of clinical nutrition products may be limited in certain regions of the country.

Competition from Traditional and Herbal Remedies: Mexico has a strong tradition of using herbal and traditional medicine practices. Some consumers may prefer to use these alternative remedies over clinical nutrition products, which can create competition and slow the adoption of specialized nutrition solutions.

Regulatory Complexities: The regulatory framework for clinical nutrition products in Mexico can be complex, with various agencies involved in the approval and registration process. This can create barriers for new market entrants and slow the introduction of innovative products.

Regulatory Landscape and Reimbursement Scenario

Clinical nutrition regulation and reimbursement in Mexico are integrated into the country's complex healthcare system, which combines public and private sector involvement. The primary regulatory body overseeing healthcare policies, including those related to clinical nutrition, is the Ministry of Health (Secretaría de Salud). The Federal Commission for Protection against Sanitary Risks (COFEPRIS), an agency of the Ministry of Health, is responsible for regulating food, drugs, medical devices, and supplements, including those used in clinical nutrition.

Mexico's healthcare system is segmented, with different public institutions providing coverage to different population groups. The main public health insurance schemes are the Mexican Social Security Institute (IMSS) for private sector employees, the Institute for Social Security and Services for State Workers (ISSSTE) for public sector employees, and Seguro Popular (recently transformed into the Institute of Health for Wellbeing, INSABI) for those not covered by other schemes.

Reimbursement for clinical nutrition services varies depending on the specific health insurance scheme and the healthcare setting. In public institutions, basic nutritional support is typically included in overall patient care, particularly for inpatient services. However, coverage for specialized nutritional interventions or long-term nutritional therapies can be limited and may require out-of-pocket payments.

The extent of coverage for clinical nutrition services under these public schemes has been expanding, particularly with the introduction of INSABI, which aims to provide free healthcare services and medications to all Mexicans not covered by other social security institutions. However, the implementation of this new system is still in progress, and its impact on clinical nutrition services remains to be fully realized.

Competitive Landscape

Key Players

Here are some of the major key players in the Mexico Clinical Nutrition Market:

• Herbalife
• GNC
• Productos Medix
• Amway
• FEMSA
• Abbott Nutrition
• Pfizer Inc.
• Bayer AG
• Nestle
• Danone